Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf your Mounjaro pen arrived warm rather than cold, the key question is how warm and for how long. Tirzepatide can tolerate being outside the fridge for a limited period, but that window has strict boundaries set out in the manufacturer's guidance. Using a pen that has exceeded its room-temperature limit carries genuine risk, and the right response depends on your specific circumstances. These are prescription-only medicines, and any uncertainty about a pen's integrity is worth raising with a prescriber or pharmacist before you inject. For context on how Mounjaro is stored and transported through a regulated supply chain, the Mounjaro delivery guidance on this site sets out what to expect from a legitimate UK pharmacy shipment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Not necessarily, and this is the misconception worth clearing up gently: a pen that is not ice-cold on arrival has not automatically been rendered useless. The Mounjaro KwikPen is licensed to tolerate room temperature (up to 30°C) for a defined period after removal from the fridge. The exact duration is specified in the Mounjaro SmPC on the eMC, and that is the authoritative source, not a forum, not a rough rule of thumb.
What matters is whether the pen breached that window, and by how much. A pen that spent two hours on a courier van on a mild autumn day is a very different situation from one left in a car in direct July sun. The temperature inside a DPD transit bag differs from ambient air temperature, and insulated packaging matters. None of that makes guesswork acceptable, but it does mean the answer is genuinely case-by-case rather than a blanket write-off.
The honest position is this: if you cannot confirm the pen stayed within the permitted range, you need a prescriber's input before using it. Our FAQs touch on storage questions, and our prescribers are reachable seven days a week for exactly this kind of query.
No, and that matters. Heat-degraded tirzepatide does not turn cloudy, change colour, or produce visible particles in most cases. The solution can look perfectly clear and normal while the active protein has partially denatured. This is one of the reasons why visual inspection, though worth doing (check for particles, cloudiness, or discolouration as a basic step), cannot substitute for staying within the validated storage conditions.
The NHS guidance on tirzepatide is direct on this point: follow the storage instructions in the leaflet and seek advice if you are unsure. The NHS tirzepatide medicines page is a useful first reference, and the SmPC carries the definitive temperature thresholds.
If you are a transfer patient or have received your pen from a source you cannot fully verify, the storage question intersects with a broader supply-chain one. The MHRA has issued clear warnings about counterfeit GLP-1 pens circulating in the UK, and pens obtained outside the licensed supply chain may have been stored incorrectly throughout their journey, not just on the final leg. Our guide on what to do when Mounjaro arrives not cold covers those scenarios in more detail.
Your first call should be to the pharmacy that dispensed the pen. A GPhC-registered pharmacy has a duty of care that extends past the moment of dispatch, and a prescriber or pharmacist can help you assess whether the pen is likely to be within tolerance or whether a replacement is needed.
At nume, our prescribers are available seven days a week for aftercare queries, this is precisely the kind of situation that benefits from a real clinician's judgement rather than a general rule. If you are a patient with an existing condition that makes a missed or delayed dose more significant, such as type 2 diabetes, that context changes the urgency of the conversation, and it is also worth knowing that our overview of how Mounjaro affects the liver covers relevant metabolic considerations for patients with complex health backgrounds. Our clinical team can advise on next steps specific to your treatment.
If you suspect the pen was not properly refrigerated before dispatch, or if you received it from an unverified source, you can report the concern to the MHRA via the Yellow Card scheme. The scheme accepts reports about suspect medicines and sellers, and that information helps the regulator track storage and supply failures.
One practical note: do not use a pen you are uncertain about simply because replacing it feels inconvenient or costly. The cost of a replacement pen, considered against the risk of injecting degraded medication, is not a close call. Patients who are also managing metabolic conditions may find our page on Mounjaro and fatty liver relevant to their wider treatment picture. You can explore how Mounjaro is priced through private services if a replacement is what's needed, and our free consultation page is the starting point for anyone establishing or continuing treatment with us, including those who want tirzepatide delivered directly and safely to their door.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.